Russia's R-Pharm secures approval of coronavir for outpatients

Russia's R-Pharm secures approval of coronavir for outpatients
Representative Image Image Credit: ANI
  • Country:
  • Russian Federation

Russia's R-Pharm on Friday announced the approval of coronavir for outpatient treatment of mild to moderate COVID-19 coronavirus infection, it said in a statement.

Coronavir, manufactured at R-Pharm's facility in Yaroslavl, will be available in pharmacies, the company added without elaborating.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.